Biotech, you may not be in position to answer this but Ill ask anyway...
why hasn't your company decided to purchase ADO's products if they can achieve a 30%+ cost saving on the plates?
Is it because change in supplier (or change generally) is slow in the medical arena?
I believe in the disruptive story of ADO and it is a potential game changer for pathology labs and beyond.
The unknown I guess is the pace of change (and therefore revenue streams from direct product selling and royalties from large third party contracts)
Its all a waiting game. but my bet is it will just take a couple of large companies to make the change to mix n go and small and medium companies will follow.
Exciting times for ADO (and shareholders)
Maddoc
Biotech, you may not be in position to answer this but Ill ask...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.0¢ |
Change
-0.001(4.76%) |
Mkt cap ! $49.36M | |||
| Open | High | Low | Value | Volume |
| 2.1¢ | 2.1¢ | 2.0¢ | $10.34K | 499.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 2923983 | 2.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 196776 | 4 |
View Market Depth
| Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
| ADO (ASX) Chart |